For years, semaglutide was framed as a powerful tool for diabetes and weight loss. Now cardiologists are confronting a more ...

Semaglutide can help the body make more insulin and improves insulin sensitivity, which in turn lowers blood-glucose levels and improves blood-sugar control.The benefits are wide: About 35 percent of ...

Chances are, you haven’t heard of metabolic dysfunction–associated steatohepatitis (MASH)—but you’ve almost definitely heard murmurs about GLP-1 medications like Ozempic and Wegovy. Well, the two are ...

Semaglutide significantly improved liver fibrosis and steatohepatitis resolution in MASH patients over 72 weeks compared to placebo. The study involved 800 patients receiving semaglutide and 400 ...

Heart disease continues to claim millions of lives annually, with obesity and excess weight dramatically increasing risk. While lifestyle modifications remain foundational for cardiovascular health, ...

Please provide your email address to receive an email when new articles are posted on . Semaglutide positively affected renal fat mass, glomerular hemodynamics, inflammation and cortical fibrosis.

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...

A new study led by a researcher at University College London (UCL) suggests that the anti-obesity drug semaglutide may reduce ...